The 222 patients treated with Erbitux and chemotherapy survived for an average of 40 weeks.
The 222 patients treated with Erbitux and chemotherapy survived for an average of 40 weeks.
接受艾比特思和化学疗法联合治疗的222名患者平均幸存了40周。
The 222 patients treated with Erbitux and chemotherapy survived for an average of 40 weeks.
接受艾比特思和化学疗法联合治疗的222名患者平均幸存了40周。